Dr. Meera Oza, MD
What this data tells you about Dr. Oza
Dr. Meera Oza is a rheumatology in Orange Park, FL, with 19 years in practice. Based on federal Medicare data, Dr. Oza performed 294,828 Medicare services across 3,873 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oza received a total of $11,149 from 34 pharmaceutical and/or device companies across 670 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 113,600 | $4 | $12 |
| Tocilizumab injection (Actemra) | 80,080 | $5 | $10 |
| Abatacept infusion (Orencia) | 48,625 | $34 | $71 |
| Romosozumab injection (Evenity) for osteoporosis | 31,710 | $8 | $16 |
| Denosumab injection (Prolia/Xgeva) | 6,960 | $18 | $37 |
| Injection, rituximab, 10 mg | 4,850 | $64 | $135 |
| Blood draw (venipuncture) | 1,152 | $8 | $10 |
| Methotrexate sodium, 5 mg | 1,010 | $0 | $10 |
| Administration of chemotherapy into vein, 1 hour or less | 967 | $99 | $250 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 959 | $55 | $115 |
| Office visit, established patient (30-39 min) | 925 | $95 | $200 |
| Steroid injection (triamcinolone) | 796 | $1 | $10 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 425 | $4 | $15 |
| Infusion, normal saline solution, 250 cc | 267 | $1 | $25 |
| X-ray of hand, 2 views | 237 | $23 | $65 |
| Administration of chemotherapy into vein, each additional hour | 225 | $22 | $75 |
| Joint injection, major joint | 191 | $48 | $105 |
| Office visit, established patient, complex (40-54 min) | 168 | $133 | $250 |
| Drug injection, under skin or into muscle | 152 | $11 | $40 |
| Injection of trigger points, 3 or more muscles | 148 | $43 | $110 |
| Foot X-ray, 3+ views | 137 | $25 | $50 |
| Injection into tendon or ligament | 126 | $33 | $110 |
| Bone density scan (DEXA) | 117 | $37 | $200 |
| Mri scan of arm without contrast | 96 | $175 | $750 |
| X-ray of knee, 1-2 views | 91 | $26 | $50 |
| Mri scan of arm joint without contrast | 82 | $104 | $750 |
| Chest X-ray, 2 views | 79 | $18 | $60 |
| Office visit, established patient (20-29 min) | 70 | $66 | $150 |
| Injection of additional new drug or substance into vein | 68 | $12 | $40 |
| X-ray of upper spine, 4-5 views | 63 | $39 | $90 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 63 | $3 | $20 |
| Injection, diphenhydramine hcl, up to 50 mg | 62 | $1 | $6 |
| X-ray of lower and sacral spine, minimum of 4 views | 45 | $39 | $120 |
| X-ray of joint between lower spine and hip bone, 1-2 views | 42 | $26 | $80 |
| New patient office visit, complex (60-74 min) | 42 | $155 | $320 |
| Hip X-ray, 2-3 views | 40 | $33 | $80 |
| Shoulder X-ray, 2+ views | 33 | $27 | $65 |
| Injection into tendon at attachment to bone or muscle | 27 | $35 | $110 |
| Mri scan of leg joint without contrast | 24 | $106 | $750 |
| Aspiration and/or injection of fluid from small joint | 16 | $35 | $80 |
| X-ray of joint between lower spine and hip bone, 3 or more views | 16 | $30 | $100 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $95 | $191 |
| Aspiration and/or injection of fluid from medium joint | 13 | $29 | $85 |
| Analysis of urine, except immunoassays | 13 | $2 | $10 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Oza is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Oza experienced with certolizumab injection (cimzia)?
Does Dr. Oza receive payments from pharmaceutical companies?
How do Dr. Oza's costs compare to other rheumatologys in Orange Park?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology